Skip to main content

Condition · 3 treatment paths

Prostate Cancer

Prostate cancer is a cancer of the gland beneath the bladder, mainly found in men over 50. Treatment decisions depend on how aggressive and how far-spread the cancer is.

Severe

Send your imaging + plan. Board-reviewed opinion in 5–10 working days.

Last updated: How we source & review

Linear accelerator used for radiotherapy in a cancer treatment room
Treatment paths
3Treatment paths
Specialties
2Specialties
Typical severity
SevereTypical severity

About prostate cancer

What to know

Early disease often causes no symptoms and is found through a raised PSA blood test or an abnormal rectal examination. Later signs include urinary difficulty or bone pain. Diagnosis involves MRI of the prostate and a biopsy, which gives a Gleason grade, and staging scans if risk is higher. Many cancers grow slowly, while others are aggressive.

Low-risk cancer is often managed by active surveillance. Localised disease can be treated by surgery, such as robotic radical prostatectomy, or radiotherapy, including IMRT and proton beam therapy, usually with hormone treatment for higher-risk disease. Each carries risks to urinary and sexual function. Advanced disease is treated with hormone therapy and other medicines. Some men travel abroad to access robotic surgery or proton beam therapy.

Pre-flight workup

Tests to have already done

  • PSA results over time, with dates, and PSA density if prostate volume is known.
  • Biopsy pathology report with Gleason score or ISUP grade group, the number of positive cores and percentage of cancer in each.
  • Multiparametric prostate MRI images and report, including any PI-RADS scores.
  • Staging scans where needed for higher-risk disease, such as PSMA PET, bone scan or CT.
  • Medicines, heart and urinary history, and baseline erection and continence status, which influence the choice of treatment.

Second opinion

When to get a second look

  • Your biopsy was done without a prostate MRI, so the true extent or grade may be underestimated.
  • Your cancer is low risk and immediate surgery or radiotherapy is advised without discussing active surveillance.
  • Surgery and radiotherapy are both offered and you want a balanced comparison of side effects.
  • Your pathology report has been reported by a non-specialist and the grade is uncertain.

Talking to your doctor

Questions to ask

  1. What is my Gleason score or grade group and what risk category does that put me in?
  2. Has the cancer spread outside the prostate according to my scans?
  3. Is active surveillance safe for me, and what would trigger treatment?
  4. How do surgery, radiotherapy and proton therapy compare for my risk group?
  5. What are the chances of urinary leakage and erection problems with each option?
  6. How will my PSA be followed afterwards, and what rise would mean the cancer has returned?

Outlook

Realistic prognosis

Outcomes depend on the stage and grade at diagnosis. For cancer confined to the prostate, 10-year cancer-specific survival is very high, and many low-risk cancers never become life-threatening. Higher-grade or spread disease needs combined treatment and has a less certain outlook. Side effects such as urinary and sexual problems vary by treatment and age.

Diagnostic workup

Before you pick a hospital, get the workup right

Severe — workup typically within 48–72 hours

Picking the right treatment is downstream of a complete diagnosis. Skip steps here and the destination surgeon usually re-orders them anyway — at higher cost and another week on the ground.

  1. Confirm the diagnosis on imaging or labs

    For prostate cancer, plan on the workup your home doctor would order anyway — typically a recent specialist consult plus the imaging / labs the destination team will need to quote accurately. Anything older than 90 days usually gets re-done.

  2. See a oncology specialist locally first

    An in-person clinical exam at home — even a single consult — costs little and dramatically improves the destination plan. Bring back: written impression, recommended procedure, surgical-risk class, and any contra-indications.

  3. Send us the file for a free second opinion

    Two surgeons in our medical panel review the workup independently. They tell you whether they'd operate, watch, or refer — even if that means recommending against travel.

  4. Pick a path with timeline + cost in writing

    Once a treatment is the right call, we line up 2–3 hospital options with itemized quotes, surgeon profiles, and a travel timeline. You hold the file — switch hospitals or step away at any point.

04 · FAQ

Common questions about prostate cancer

Does prostate cancer always need treatment?

No. Low-risk disease can often be watched with regular PSA tests, MRI and sometimes repeat biopsy, so treatment is delayed or avoided.

Which is better: surgery or radiotherapy?

For localised disease, both offer similar cancer control. They differ in side effects and recovery, so the choice depends on your age, health and preferences.

Will treatment affect my sex life?

Often temporarily or permanently, with some risk of erection problems and urinary leakage, depending on treatment and your baseline function. Ask for personal estimates and rehabilitation options.

Can it come back?

Yes. A rising PSA after treatment can signal recurrence, which is why long-term follow-up is needed.

Clinical context

Working up prostate cancer properly

A condition like prostate cancer is rarely well-served by jumping straight to treatment shopping. The sequence below is what a oncology specialist would expect to see completed — and the absence of any step is the right cue to delay travel decisions.

Diagnostic workup, in sequence

  1. First-line clinical assessment

    History, physical exam, and risk-factor review by a senior generalist or oncology specialist. Symptoms list, family history, prior workup notes, and current medication list should travel with the patient.

  2. Standard imaging + labs

    Baseline blood work, condition-specific imaging (ultrasound / X-ray / MRI / CT — depending on indication), and ECG / pulmonary function as relevant. Bring digital copies of any prior imaging — saves repeat scans and the cost that goes with them.

  3. Specialist diagnostic workup

    Procedure-specific tests — biopsy, cardiac catheterisation, endoscopy, or genetic / molecular profiling depending on the suspected diagnosis. Done at the centre that will treat, ideally, so results integrate cleanly into the treatment plan.

  4. Multidisciplinary review (where indicated)

    Cancer, complex cardiac, transplant, and rare-disease cases should be reviewed by a multidisciplinary panel — surgical, medical, imaging, and pathology — before any treatment commits. Single-discipline plans for complex disease are a quality red flag.

When to escalate urgently

  • Acute worsening of established symptoms — sudden chest pain, shortness of breath at rest, neurological deficit, severe bleeding, persistent high fever.
  • Loss of consciousness, severe persistent vomiting, or any focal neurological event.
  • Symptoms in the early hours of onset that fit a time-sensitive treatment window (stroke, MI, sepsis) — every hour costs outcome.
  • If you are travelling internationally for treatment and develop these symptoms in transit, divert to the nearest emergency department; do not wait to reach the planned destination.

Before you book international travel

  • Confirm your specific diagnosis is fully worked up before you commit to a treatment plan abroad. Travelling for the workup is fine; travelling for treatment without the workup done is not.
  • Get your case reviewed remotely by the destination centre's team before you book flights — credible international patient programs review imaging + reports before they confirm the surgical plan.
  • Bring a digital + physical copy of your full medical record: imaging on USB drive in DICOM format, labs in PDF, current medication list with dosages, allergies, and any prior surgical reports.
  • Plan for longer recovery + post-discharge therapy continuation before you fly — the surgery itself is rarely the bottleneck.
  • Confirm that follow-up imaging and any necessary in-person reviews can be done at home — a treatment plan that requires repeat international trips is more burdensome (and more expensive) than the headline procedure.
How this page is made

Methodology and editorial standards

This prostate cancer overview is written by the editorial team from published Oncology sources and lists 3 treatment options offered by hospitals on our network. The page shows its last-updated date. Clinical descriptions are editorial — your treating clinician confirms what's right for your specific case.

  1. Hospital data. Hospital details are compiled from public sources and hospital websites. Accreditation (JCI, NABH and others) is shown where we hold a record of it. Always ask the hospital for its current certificate.
  2. Doctor credentials. Qualifications, specialty and bio come from the doctor's hospital profile. Licence is checked against the national medical-council register only where the profile shows a "Licence verified" badge with a date.
  3. Prices. Price ranges are indicative, compiled from hospital price lists and packages and shown with the date last updated. The hospital's written quote is what you pay against.
  4. Clinical text. Written by the Medcasts editorial team from published clinical sources. Unless a named reviewer is shown on the page, it has not been reviewed by a doctor.
  5. Independence. Hospitals cannot pay to change their position on our pages.
Data sources for this page
Peer-reviewed clinical guidelines (NCCN, ESMO, ESC, AHA, NICE — by indication)WHO ICD-11 condition classificationNational medical society treatment protocolsJCI accreditation registry

Next step · Prostate Cancer

Free second opinion on your Prostate case.

Share imaging and the current plan. Multidisciplinary board returns a written opinion within 5–10 working days — no obligation to travel.